BRIEF-Park Dental Partners- IPO Price Expected Between $12.00 And $14.00 Per Share - SEC Filing-February 2024-www.financetom.com

BRIEF-Park Dental Partners- IPO Price Expected Between $12.00 And $14.00 Per Share - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Park Dental Partners- IPO Price Expected Between $12.00 And $14.00 Per Share - SEC Filing

Sep 24, 2025 2:55 PM

Sept 24 (Reuters) -

* PARK DENTAL PARTNERS INC - IPO PRICE EXPECTED BETWEEN

$12.00 AND

$14.00 PER SHARE - SEC FILING

* PARK DENTAL PARTNERS INC - INITIAL PUBLIC OFFERING OF 1.5

MILLION SHARES OF COMMON STOCK - SEC FILING

Source text:

Further company coverage: [ ]

Previous page： MakeMyTrip narrows loss to Rs 78 crore, elevates Rajesh Magow as Group CEO Next page： Adani, Vedanta looking to buy Lanco’s power plant, says report

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

MakeMyTrip narrows loss to Rs 78 crore, elevates Rajesh Magow as Group CEO

Feb 11, 2020

Online travel company MakeMyTrip on Tuesday reported a lower adjusted operating loss of Rs 78 crore ($11 million) for the third quarter. The company also announced elevation of Rajesh Magow as the group chief executive officer while founder Deep Kalra will take up the role of executive Chairman.

Adani, Vedanta looking to buy Lanco’s power plant, says report

Feb 12, 2020

The development comes after expression for interest was invited in December as the plant was admitted for insolvency proceedings by the National Company Law Tribunal (NCLT) last year.

Shemaroo says economic slowdown impacted business from YouTube

Feb 12, 2020

Shemaroo Entertainment delivered tepid numbers in the December quarter. Hiren Gada, CEO and CFO of Shemaroo Entertainment, discussed the company's performance and the outlook for the 2020 in an interview with CNBC-TV18.

GAIL expects improvement in petchem earnings in Q4, says MD Ashutosh Karnatak

Feb 12, 2020

Ashutosh Karnatak, chairman and MD of GAIL, said that by the end of the fourth quarter, the petchem business should be positive. In terms of LNG, GAIL has made its plant 100 percent available for production, he added.